Physician

Mrugesh Prahlad Patel, MD

According to 2025 Medicare claims, Mrugesh Patel, MD (NPI: 1821030743) practices medical oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76022-6920.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 444 traditional Medicare patients, billed 111,185 HCPCS/CPT codes, and received $1,632,428 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 569 prescription claims across 94 beneficiaries totaling $3,179,822 in drug costs, led by Revlimid (Lenalidomide). 2019 DME data shows 29 claims. Open Payments data shows 14 records totaling $286. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,034,417 to $1,632,428. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,027,787 and ending at $3,179,822. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$816K$1.6M2015 Medicare payment: $1,034,417 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,271,545 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,044,503 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,025,466 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $989,511 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,467,604 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,305,234 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,400,061 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,468,740 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,632,428 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201536879,027$1,034,417
2016489126,459$1,271,545
2017502109,796$1,044,503
2018467134,502$1,025,466
2019455106,654$989,511
2020430139,456$1,467,604
2021465110,177$1,305,234
2022468123,875$1,400,061
2023464142,541$1,468,740
2024444111,185$1,632,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2015 Drug cost: $1,027,787 (USD; Tot_Drug_Cst)2016 Drug cost: $1,395,119 (USD; Tot_Drug_Cst)2017 Drug cost: $1,169,768 (USD; Tot_Drug_Cst)2018 Drug cost: $1,016,610 (USD; Tot_Drug_Cst)2019 Drug cost: $903,695 (USD; Tot_Drug_Cst)2020 Drug cost: $762,046 (USD; Tot_Drug_Cst)2021 Drug cost: $810,955 (USD; Tot_Drug_Cst)2022 Drug cost: $1,111,286 (USD; Tot_Drug_Cst)2023 Drug cost: $1,596,739 (USD; Tot_Drug_Cst)2024 Drug cost: $3,179,822 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015156775$1,027,787
2016145832$1,395,119
2017148761$1,169,768
2018146759$1,016,610
2019113509$903,695
202094407$762,046
202184345$810,955
202278325$1,111,286
202387417$1,596,739
202494569$3,179,822

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.0K$18K2015 Medicare payment: $17,997 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $996 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,340 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R86$17,997
2016N/R39$996
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R29$5,340
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more178342$94
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's122172$11
80053Blood test, comprehensive group of blood chemicals203415$10
36415Insertion of needle into vein for collection of blood sample149351$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count197475$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide471,302$953,403
ImbruvicaIbrutinib551,540$851,798
PomalystPomalidomide16448$376,313
TasignaNilotinib Hcl11308$255,948
JakafiRuxolitinib Phosphate12360$103,624

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$286Celgene Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mrugesh Prahlad Patel, MD?

Tedicare shows public-source Medicare data for Mrugesh Prahlad Patel, MD (NPI 1821030743), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mrugesh Prahlad Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mrugesh Prahlad Patel, MD?

Mrugesh Prahlad Patel, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1033386578) in the available physician profile data.

Does Mrugesh Prahlad Patel, MD have Open Payments data?

Mrugesh Prahlad Patel, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.